QR 060
Alternative Names: QR-060Latest Information Update: 31 Oct 2023
At a glance
- Originator Wuhan Createrna Science and Technology
- Class Analgesics; Antitussives; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cough; Pain
- Discontinued Diabetic nephropathies; Focal segmental glomerulosclerosis
Most Recent Events
- 23 Oct 2023 Discontinued - Preclinical for Diabetic nephropathies in China (unspecified route) (Wuhan Createrna Science and Technology pipeline, October 2023)
- 23 Oct 2023 Discontinued - Preclinical for Focal segmental glomerulosclerosis in China (unspecified route) (Wuhan Createrna Science and Technology pipeline, October 2023)
- 23 Oct 2023 Phase-I clinical trials in Cough in China (unspecified route) (Wuhan Createrna Science and Technology pipeline, October 2023)